Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAGE-C1 (Melanoma Antigen Gene Family, C1) is a cancer-testis antigen expressed in various tumors, particularly multiple myeloma, but largely absent from normal tissues except for the testis. It plays a role in promoting tumor cell survival and is a promising target for immune-based therapies. Expression levels may also serve as a prognostic marker in certain cancers.
Currently under investigation; likely involves disrupting tumor cell survival pathways and enhancing immunogenicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAGE family member C1 (MAGE-C1).